Showing results (591-600 of 1,593) with videos related to

Sort By:
Pageof 160
JAMA Psychiatry|April 12, 2013
A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependenceEugene C Somoza, Douglas Winship, Charles W Gorodetzky, et al.
JAMA Psychiatry|May 24, 2013
Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trialJaime E C Hallak, Joao Paulo Maia-de-Oliveira, Joao Abrao, et al.
JAMA Psychiatry|February 22, 2013
Adult psychiatric outcomes of bullying and being bullied by peers in childhood and adolescenceWilliam E Copeland, Dieter Wolke, Adrian Angold, et al.
JAMA Psychiatry|September 25, 2014
Comparison of 2 family therapies for adolescent anorexia nervosa: a randomized parallel trialW Stewart Agras, James Lock, Harry Brandt, et al.
JAMA Psychiatry|September 27, 2013
A nationwide study of the association between celiac disease and the risk of autistic spectrum disordersJonas F Ludvigsson, Abraham Reichenberg, Christina M Hultman, et al.
JAMA Psychiatry|October 25, 2013
State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislationHefei Wen, Janet R Cummings, Jason M Hockenberry, et al.
JAMA Psychiatry|November 1, 2013
Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 monthsAaron S Heller, Tom Johnstone, Michael J Peterson, et al.
JAMA Psychiatry|October 18, 2013
Topiramate for the treatment of cocaine addiction: a randomized clinical trialBankole A Johnson, Nassima Ait-Daoud, Xin-Qun Wang, et al.
JAMA Psychiatry|October 18, 2013
Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhoodHazel McCarthy, Norbert Skokauskas, Aisling Mulligan, et al.
JAMA Psychiatry|October 17, 2014
Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP studyChristoph U Correll, Delbert G Robinson, Nina R Schooler, et al.
Pageof 160